Mike Wilson: A New Cyclical Upturn?

Mike Wilson: A New Cyclical Upturn?

With uncertainty around the effects of new central bank policy, investors should be on the lookout for sales growth, cost cutting and sectors that might be turning a corner on performance.


----- Transcript -----

Welcome to Thoughts on the Market. I'm Mike Wilson, Chief Investment Officer and Chief U.S. Equity Strategist for Morgan Stanley. Along with my colleagues bringing you a variety of perspectives, I'll be talking about the latest trends in the financial marketplace. It's Monday, July 31st, 11 a.m. in New York. So let's get after it.


This past week was an extremely busy one for global central banks, with the Fed and European Central Bank raising interest rates again by 25 basis points, while leaving the door open to either more hikes or pausing indefinitely. They remain data dependent. However, the biggest change may have come from the Bank of Japan. More specifically, the Bank of Japan decided to get the ball rolling on ending its long standing policy of yield curve control, a policy under which it maintains a cap on interest rates across the curve. This is an important pivot in our view, as it signals the Bank of Japan's willingness to join the fight against inflation. In short, it's incrementally hawkish for global bond markets.


For U.S. equity investors, the main focus has been on the Fed getting closer to the end of its tightening campaign. The key question from investors is whether that means the Fed has orchestrated a soft landing or if a recession is unavoidable. While many investors remain skeptical of the soft landing outcome, equity markets have traded so well this year that these same investors have been swayed into thinking a soft landing is now the highest probability outcome. We believe equity markets are in a classic policy driven late cycle rally. Furthermore, the excitement over a Fed pause has been supported by very strong fiscal impulse and a still supportive global liquidity backdrop, even with central banks tightening. The latest example of a similar late cycle period occurred in 2019. Back then, a robust rally in equities was driven almost exclusively by valuations rather than earnings, like this year. Both then and now, Mega- cap growth stocks were the best performers as equity market internals processed a path to easier monetary policy and lower interest rates. The 2019 analogy suggests more index level upside from here, however, we would note that the Fed was already cutting interest rates for a good portion of 2019, leaving ten year Treasury yields 200 basis points lower than they are today. Nevertheless, equity valuations are 5% higher now than in 2019.


The other scenario is that we are in a new cyclical upturn and growth is about to reaccelerate sharply for both the economy and earnings. While we're open minded to this new view materializing next year, we'd like to see a broader swath of business cycle indicators inflect, higher, breadth improve and short term interest rates come down before adjusting our stance in this regard. In other words, the current progression of these factors does not yet look like prior new cyclical upturns.


Meanwhile, earnings season has been a fade the news so far, with the average stock down about 1% post results. This is worse than the past eight quarters where stocks are flat to up. While hardly a disaster, we think companies will have to start delivering better sales growth to outperform from here. On that score, even the large cap growth stocks have been mostly cost cutting stories to date. Another interesting observation over the past month is that the worst performing sectors are starting to exhibit the best breadth of performance, namely energy, utilities and health care. Industrials is the only leading sector with improving breath. Given the uncertainty there remains about the economic outcome in central bank policy, investors should look to the laggards with good breadth for relative performance catch up. Our top picks are healthcare, utilities and energy.


Thanks for listening. If you enjoy Thoughts on the Market, please take a moment to rate and review us on the Apple Podcasts app. It helps more people to find the show.

Jaksot(1514)

Special Episode, Part 2: Coronavirus - Building Models to Rebuild Economies

Special Episode, Part 2: Coronavirus - Building Models to Rebuild Economies

When do we return to work? The market reaction? The drug pipeline? Chief Cross-Asset Strategist Andrew Sheets and Head Biotech Equity Analyst Matthew Harrison continue their discussion on the impact of the Covid-19 pandemic.

14 Huhti 202010min

Mike Wilson: U.S. Markets React to Fed Moves

Mike Wilson: U.S. Markets React to Fed Moves

If there is one lesson to be learned from the financial repression era it's that when risk premium appears, investors may want to make moves before it evaporates.

13 Huhti 20204min

Special Episode: Coronavirus – Building Models to Rebuild Economies

Special Episode: Coronavirus – Building Models to Rebuild Economies

How do you track a virus, a global economy and a road to recovery? On this special episode, an engaging conversation with our Chief Cross-Asset Strategist and Head Biotech Equity Analyst.

9 Huhti 20209min

Michael Zezas: Another Dose of Fiscal Stimulus?

Michael Zezas: Another Dose of Fiscal Stimulus?

The U.S. Congress has been debating ways to flatten another worrying curve: the sliding economic growth curve. What form could additional fiscal stimulus take?

8 Huhti 20202min

Mike Wilson: What Are Markets Thinking?

Mike Wilson: What Are Markets Thinking?

Asset prices often reflect the obvious before it becomes obvious. So the question for investors now is, "What is the market thinking about that's not obvious?"

6 Huhti 20203min

Andrew Sheets: Optimism for Credit Markets

Andrew Sheets: Optimism for Credit Markets

Even as economic and public health data get worse, recent changes in three key factors make global credit markets an attractive option. Our Chief Cross-Asset Strategist, Andrew Sheets, explains.

3 Huhti 20202min

Michael Zezas: What Does the CARES Act Buy?

Michael Zezas: What Does the CARES Act Buy?

The $2 trillion CARES Act includes a variety of provisions that will help preserve the financial health of state and local governments, hospitals and airports. Here’s what’s inside.

1 Huhti 20202min

Mike Wilson: U.S. Equities - Is the Worst Behind Us?

Mike Wilson: U.S. Equities - Is the Worst Behind Us?

Although economic and earnings data could be gloomy over the next month, have equity markets already discounted the bad news? Detailed analysis from Chief Investment Officer Mike Wilson.

30 Maalis 20203min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
herrasmieshakkerit
rss-rahamania
ostan-asuntoja-podcast
lakicast
rss-neuvottelija-sami-miettinen
pari-sanaa-lastensuojelusta
rss-lahtijat
rss-startup-ministerio
taloudellinen-mielenrauha
oppimisen-psykologia
syo-nuku-saasta
rahapuhetta
yrittaja
hyva-paha-johtaminen
rss-myyntikoulu
rss-seuraava-potilas